"So how's it going?"
"Pretty good. Pretty good."
I want my patients to know that we care about all aspects of their health. We are always trying to push the boundaries of new treatments and how to improve their lives.
My name is Eli Diamond, and I'm a neuro-oncologist at Memorial Sloan Kettering Cancer Center. And I specialize in the research and treatment of patients with Erdheim-Chester disease, other histiocytic conditions, and brain tumors.
The histiocytic diseases are a family of blood cancers that affect people's health in a variety of ways.
"Your scans have been looking absolutely terrific."
When patients come to see me, they want to know what the future holds. They want to understand more about this rare condition they have. And they want to be reassured that someone is familiar with what they're going through. It's so important for patients with a rare disease to be treated by a team of people who are very, very familiar with the condition.
There have been tremendous advances in this field as a result of our research and our trials at Memorial Sloan Kettering. We've discovered a lot more about the gene mutations that cause the histiocytic conditions and how those can be treated with gene-blocking medicines.
Patients with rare cancers often have nowhere to turn. And they need someone who is going to pick up the cause and really understand their disease and find ways to treat it. That's why I see it as my mission to take on the histiocytic diseases.